Prestige Consumer Healthcare PBH Eye & Ear Care — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's eye & ear care — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prestige Consumer Healthcare's eye & ear care — total revenues?
- Prestige Consumer Healthcare (PBH) reported eye & ear care — total revenues of $37.85M in Q1 2026.
- How has Prestige Consumer Healthcare's eye & ear care — total revenues changed year-over-year?
- Prestige Consumer Healthcare's eye & ear care — total revenues decreased by 19.0% year-over-year, from $46.73M to $37.85M.
- What is the long-term trend for Prestige Consumer Healthcare's eye & ear care — total revenues?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's eye & ear care — total revenues has grown at a -3.3% compound annual growth rate (CAGR), from $163.45M to $142.94M.
- What does eye & ear care — total revenues mean?
- This metric represents the total gross revenue generated from the sale of eye and ear care products within the company's consumer healthcare portfolio. It reflects the market demand and commercial performance of brands focused on ocular and auditory health, such as redness relief solutions. Monitoring this figure helps investors assess the growth trajectory and competitive positioning of the company's specialized healthcare offerings.